{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T16:18:51Z","timestamp":1775060331307,"version":"3.50.1"},"reference-count":33,"publisher":"American Society of Clinical Oncology (ASCO)","issue":"6","content-domain":{"domain":["ascopubs.org"],"crossmark-restriction":true},"short-container-title":["JCO Oncology Practice"],"published-print":{"date-parts":[[2020,6]]},"abstract":"<jats:p> Recent studies have identified durable responses with the use of immune checkpoint inhibitors in patients with mismatch repair\u2013deficient (MMR-D)\/microsatellite instability\u2013high (MSI-H) metastatic colorectal cancer (CRC). The dramatic improvement in clinical outcomes led to the US Food and Drug Administration approval of pembrolizumab, nivolumab, and nivolumab in combination with ipilimumab in metastatic patients with MSI-H\/MMR-D CRC who previously experienced progression on cytotoxic therapies. In the clinical trials investigating these agents, HIV-seropositive patients were not included and therefore the clinical efficacy of these agents in patients with metastatic MSI-H\/MMR-D CRC living with HIV is unclear. On the basis of growing evidence, immune checkpoint blockade therapies seem to be a safe approach in patients with well-controlled HIV infection. Research on immunotherapeutic approaches in patients living with HIV and cancer is an area of unmet medical need that can be addressed by clinical trial designs that are inclusive of patients with well-controlled seropositive HIV and trials that specifically evaluate immune therapies in patients living with HIV. <\/jats:p>","DOI":"10.1200\/jop.19.00754","type":"journal-article","created":{"date-parts":[[2020,3,11]],"date-time":"2020-03-11T19:59:28Z","timestamp":1583956768000},"page":"319-325","update-policy":"https:\/\/doi.org\/10.1200\/crossmark","source":"Crossref","is-referenced-by-count":21,"title":["Safety and Efficacy of Immune Checkpoint Inhibitors in Patients With Cancer Living With HIV: A Perspective on Recent Progress and Future Needs"],"prefix":"10.1200","volume":"16","author":[{"given":"Ibrahim Halil","family":"Sahin","sequence":"first","affiliation":[{"name":"Emory University School of Medicine, Winship Cancer Institute, Atlanta, GA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sujata R.","family":"Kane","sequence":"additional","affiliation":[{"name":"Emory University School of Medicine, Winship Cancer Institute, Atlanta, GA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edith","family":"Brutcher","sequence":"additional","affiliation":[{"name":"Emory University School of Medicine, Winship Cancer Institute, Atlanta, GA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Guadagno","sequence":"additional","affiliation":[{"name":"Emory University School of Medicine, Winship Cancer Institute, Atlanta, GA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine E.","family":"Smith","sequence":"additional","affiliation":[{"name":"Emory University School of Medicine, Winship Cancer Institute, Atlanta, GA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"Wu","sequence":"additional","affiliation":[{"name":"Emory University School of Medicine, Winship Cancer Institute, Atlanta, GA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory B.","family":"Lesinski","sequence":"additional","affiliation":[{"name":"Emory University School of Medicine, Winship Cancer Institute, Atlanta, GA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clifford J.","family":"Gunthel","sequence":"additional","affiliation":[{"name":"Emory University School of Medicine, Winship Cancer Institute, Atlanta, GA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bassel F.","family":"El-Rayes","sequence":"additional","affiliation":[{"name":"Emory University School of Medicine, Winship Cancer Institute, Atlanta, GA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"233","reference":[{"key":"b1","doi-asserted-by":"publisher","DOI":"10.1038\/ng0195-48"},{"key":"b2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(93)90331-J"},{"key":"b3","first-page":"4420","volume":"57","author":"Yamamoto H","year":"1997","journal-title":"Cancer Res"},{"key":"b4","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1155\/2004\/368680","volume":"20","author":"Pawlik TM","year":"2004","journal-title":"Dis Markers"},{"key":"b5","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaa4971"},{"key":"b6","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2009.80"},{"key":"b7","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6602534"},{"key":"b8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1500596"},{"key":"b9","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(17)30422-9"},{"key":"b10","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.76.9901"},{"key":"b11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1615896"},{"key":"b12","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.180.8.5439"},{"key":"b13","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.4049\/jimmunol.179.3.1979","volume":"179","author":"D\u2019Souza M","year":"2007","journal-title":"J Immunol"},{"key":"b14","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(16)30364-3"},{"key":"b15","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1001\/jamaoncol.2019.2244","volume":"5","author":"Uldrick TS","year":"2019","journal-title":"JAMA Oncol"},{"key":"b16","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1001\/jamaoncol.2018.6737","volume":"5","author":"Cook MR","year":"2019","journal-title":"JAMA Oncol"},{"key":"b17","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/CJI.0000000000000240","volume":"41","author":"Chang E","year":"2018","journal-title":"J Immunother"},{"key":"b18","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.36.9199"},{"key":"b19","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.1093\/annonc\/mdx538","volume":"28","author":"Heppt MV","year":"2017","journal-title":"Ann Oncol"},{"key":"b20","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1093\/annonc\/mdx696","volume":"29","author":"Guihot A","year":"2018","journal-title":"Ann Oncol"},{"key":"b21","doi-asserted-by":"crossref","first-page":"E540","DOI":"10.21037\/jtd.2017.05.32","volume":"9","author":"McCullar B","year":"2017","journal-title":"J Thorac Dis"},{"key":"b22","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1093\/annonc\/mdx817","volume":"29","author":"Lavol\u00e9 A","year":"2018","journal-title":"Ann Oncol"},{"key":"b23","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.jtho.2018.03.031","volume":"13","author":"Ostios-Garcia L","year":"2018","journal-title":"J Thorac Oncol"},{"key":"b24","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s40425-018-0379-x","volume":"6","author":"Husnain M","year":"2018","journal-title":"J Immunother Cancer"},{"key":"b25","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-18-0121"},{"key":"b26","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)07668-7"},{"key":"b27","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ctro.2018.12.004","volume":"15","author":"Linge A","year":"2019","journal-title":"Clin Transl Radiat Oncol"},{"key":"b28","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1159\/000490636","volume":"11","author":"Al Homsi MU","year":"2018","journal-title":"Case Rep Oncol"},{"key":"b29","doi-asserted-by":"crossref","first-page":"e143","DOI":"10.1016\/j.clml.2017.12.008","volume":"18","author":"Chang E","year":"2018","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"b30","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1007\/s00277-018-3541-0","volume":"98","author":"Serrao A","year":"2019","journal-title":"Ann Hematol"},{"key":"b31","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s40425-017-0252-3","volume":"5","author":"Sandoval-Sus JD","year":"2017","journal-title":"J Immunother Cancer"},{"key":"b32","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.73.7338"},{"key":"b33","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1097\/QAD.0000000000001217","volume":"30","author":"Gill AL","year":"2016","journal-title":"AIDS"}],"container-title":["JCO Oncology Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/JOP.19.00754","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,29]],"date-time":"2022-05-29T07:51:29Z","timestamp":1653810689000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/JOP.19.00754"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["10.1200\/JOP.19.00754"],"URL":"https:\/\/doi.org\/10.1200\/jop.19.00754","relation":{},"ISSN":["2688-1527","2688-1535"],"issn-type":[{"value":"2688-1527","type":"print"},{"value":"2688-1535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"2020-01-20","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-03-11","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}